Looking for MONTELUKAST 4-mg oral granules
Registered user of Farmavita.Net is looking for EU CTD Dossier with supply for MONTELUKAST, 4-mg oral granules. Product is sought for non-EU markets, where data exclusivity and patents are not in force.
Montelukast (trade name Singulair) is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually administered orally. Montelukast is a CysLT1 antagonist; that is it blocks the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1 in the lungs and bronchial tubes by binding to it. This reduces the bronchoconstriction otherwise caused by the leukotriene, and results in less inflammation.
Because of its method of operation, it is not useful for the treatment of acute asthma attacks. Again because of its very specific focus of operation, it does not interact with other allergy medications such as theophylline.
Offer is valid subject to confirmation of patent non infringement status of product. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent we do our best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties.Read also at Pharmaceutical Licensing Network
Newer news items
|< Prev||Next >|
Jobline - Job opportunities published at Farmavita.Net
At the JobLine you can post your job vacancies or search for new job opportunities. We kindly invite all members to post their demand for full-time/part-time jobs, temporary needs, consulting support, project support, internship openings and other opportunities.If you are recruiter or just looking for job ..... find below important presentation which will describe you why are social networks are important to your career.